VI
HCAT icon

Versor Investments’s Health Catalyst HCAT Stock Holding History

Versor Investments’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,900
Closed -$187K – 812
2024
Q1 		$187K Sell
24,900
-4,100
-14% -$37.4K 0.04% 623
2023
Q4 		$269K Buy
29,000
+17,400
+150% +$142K 0.05% 568
2023
Q3 		$117K Buy
+11,600
New +$138K 0.02% 630
2023
Q1 		– Sell
-12,500
Closed -$133K – 780
2022
Q4 		$133K Buy
+12,500
New +$121K 0.01% 668

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Versor Investments's HCAT Position: Q2 2024 in Review

Versor Investments sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 24,900 shares — an estimated $187K sold.

Versor Investments first reported a position in HCAT in Q4 2022 and held it in 4 quarters. The position peaked at $269K in Q4 2023. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • Versor Investments reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • Versor Investments sold 24,900 Health Catalyst shares in Q2 2024, an estimated $187K.
  • Versor Investments first reported a position in Health Catalyst in Q4 2022 and held it in 4 quarters.
  • Versor Investments's Health Catalyst position peaked at $269K in Q4 2023.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Versor Investments's 13F filing for Q2 2024, filed 1 Aug 2024.